{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:34:51Z","timestamp":1777660491623,"version":"3.51.4"},"reference-count":33,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HAB"],"published-print":{"date-parts":[[2022,5,12]]},"abstract":"<jats:p>BACKGROUND: The recently emerged SARS-CoV-2 caused a global pandemic since the last two years. The urgent need to control the spread of the virus and rapid application of the suitable health measures raised the importance of available, rapid, and accurate diagnostic approaches. OBJECTIVE: The purpose of this study is to describe a rapid in-house optimized ELISA based on the expression of the receptor binding domain (RBD) of the SARS-CoV-2 spike protein in a prokaryotic system. METHODS: We show the expression of the 30 kDa recombinant SARS-CoV-2 RBD-6\u00d7His in four different E. coli strains (at 28\u2218C using 0.25mM IPTG) including the expression strain E. coli BL21 (DE3) Rosetta Gami. SARS-CoV-2 rRBD-6\u00d7His protein was purified, refolded, and used as an antigen coat to assess antibody response in human sera against SARS-CoV-2 infection. RESULTS: The assessment was carried out using a total of 155 human sero-positive and negative SARS-CoV-2 antibodies. The ELISA showed 69.5% sensitivity, 88% specificity, 78.5% agreement, a positive predictive value (PPV) of 92.3%, and a negative predictive value of 56.5%. Moreover, the optical density (OD) values of positive samples significantly correlated with the commercial kit titers. CONCLUSIONS: Specific human antibodies against SARS-CoV-2 spike protein were detected by rapid in-house ELISA in sera of human COVID-19-infected patients. The availability of this in-house ELISA protocol would be valuable for various diagnostic and epidemiological applications, particularly in developing countries. Future studies are planned for the use of the generated SARS-CoV-2 rRBD-6\u00d7His protein in vaccine development and other diagnostic applications.<\/jats:p>","DOI":"10.3233\/hab-220003","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T13:06:13Z","timestamp":1649768773000},"page":"105-115","source":"Crossref","is-referenced-by-count":7,"title":["Assessment of specific human antibodies against SARS-CoV-2 receptor binding domain by rapid in-house ELISA"],"prefix":"10.1177","volume":"30","author":[{"given":"Nahla A.","family":"Hussein","sequence":"first","affiliation":[{"name":"Molecular Biology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esraa A.A.","family":"Ali","sequence":"additional","affiliation":[{"name":"Molecular Biology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr E.","family":"El-Hakim","sequence":"additional","affiliation":[{"name":"Molecular Biology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf A.","family":"Tabll","sequence":"additional","affiliation":[{"name":"Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, Egypt"},{"name":"Egypt Center for Research and Regenerative Medicine, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa","family":"El-Shershaby","sequence":"additional","affiliation":[{"name":"Molecular Biology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azza","family":"Salamony","sequence":"additional","affiliation":[{"name":"Egypt Center for Research and Regenerative Medicine, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed N.F.","family":"Shaheen","sequence":"additional","affiliation":[{"name":"Environmental Virology Laboratory, Water Pollution Research Department, Environmental and Climate Change Research Institute, National Research Centre, Dokki, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Ali","sequence":"additional","affiliation":[{"name":"Parasitology Department, Theodor Bilharz Research Institute, Giza, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Elshall","sequence":"additional","affiliation":[{"name":"Parasitology Department, Theodor Bilharz Research Institute, Giza, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser E.","family":"Shahein","sequence":"additional","affiliation":[{"name":"Molecular Biology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/HAB-220003_ref2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/joim.13091","article-title":"COVID-19 diagnosis and management: A comprehensive review","volume":"288","author":"Pascarella","year":"2020","journal-title":"J Intern Med"},{"key":"10.3233\/HAB-220003_ref3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.7326\/M20-1495","article-title":"Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure","volume":"173","author":"Kucirka","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.3233\/HAB-220003_ref4","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1056\/NEJMp2015897","article-title":"False Negative Tests for SARS-CoV-2 Infection-Challenges and Implications","volume":"383","author":"Woloshin","year":"2020","journal-title":"N Engl J Med"},{"key":"10.3233\/HAB-220003_ref5","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1002\/cpcy.77","article-title":"Practical Guidelines for Collection, Manipulationand Inactivation of SARS-CoV-2 and COVID-19 Clinical Specimens","volume":"93","author":"Bain","year":"2020","journal-title":"Curr Protoc Cytom"},{"key":"10.3233\/HAB-220003_ref6","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s41587-020-0513-4","article-title":"CRISPR-Cas12-based detection of SARS-CoV-2","volume":"38","author":"Broughton","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.3233\/HAB-220003_ref7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/biology9080182","article-title":"Loop-Mediated Isothermal Amplification (LAMP): A Rapid, Sensitive, Specific, and Cost-Effective Point-of-Care Test for Coronaviruses in the Context of COVID-19 Pandemic","volume":"9","author":"Augustine","year":"2020","journal-title":"Biology"},{"key":"10.3233\/HAB-220003_ref8","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1016\/S1473-3099(20)30517-X","article-title":"Serology testing in the COVID-19 pandemic response","volume":"20","author":"Peeling","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.3233\/HAB-220003_ref9","doi-asserted-by":"publisher","first-page":"104490","DOI":"10.1016\/j.meegid.2020.104490","article-title":"Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2","volume":"89","author":"Kaur","year":"2021","journal-title":"Infect Genet Evol"},{"issue":"6","key":"10.3233\/HAB-220003_ref10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/elsc.202000106","article-title":"Purification and characterization of the receptor-binding domain of SARS-CoV-2 spike protein from Escherichia coli","volume":"21","author":"He","year":"2021","journal-title":"Eng Life Sci"},{"key":"10.3233\/HAB-220003_ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10826068.2021.1941106","article-title":"Expression and functional identification of recombinant SARS-CoV-2 receptor binding domain (RBD) from E. coli system","author":"Gao","year":"2021","journal-title":"Prep Biochem Biotechnol"},{"key":"10.3233\/HAB-220003_ref12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/diagnostics11020271","article-title":"Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBDN\u2062318-V\u2062510) Expressed in Escherichia coli","volume":"11(2)","author":"M\u00e1rquez-Ipi\u00f1a","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"7807","key":"10.3233\/HAB-220003_ref13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.3233\/HAB-220003_ref14","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat Med"},{"key":"10.3233\/HAB-220003_ref15","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot101188"},{"key":"10.3233\/HAB-220003_ref16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/abio.1976.9999","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"issue":"10","key":"10.3233\/HAB-220003_ref17","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/pathogens9100803","article-title":"Development and optimization of in-house ELISA for detection of Human IgG antibody to SARS-CoV-2 full length spike protein","volume":"9","author":"Alandijany","year":"2020","journal-title":"Pathogens"},{"issue":"6518","key":"10.3233\/HAB-220003_ref18","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"key":"10.3233\/HAB-220003_ref19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2202-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.3233\/HAB-220003_ref20","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.3233\/HAB-220003_ref21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"10.3233\/HAB-220003_ref22","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.3233\/HAB-220003_ref23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.3233\/HAB-220003_ref24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.3233\/HAB-220003_ref25","doi-asserted-by":"publisher","first-page":"041506","DOI":"10.1063\/5.0021554","article-title":"Evaluation of current diagnostic methods for COVID-19","volume":"4","author":"Alpdagtas","year":"2020","journal-title":"APL Bioengineering"},{"key":"10.3233\/HAB-220003_ref26","doi-asserted-by":"publisher","first-page":"110559","DOI":"10.1016\/j.biopha.2020.110559","article-title":"Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies","volume":"130","author":"Hussain","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.3233\/HAB-220003_ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78711-6"},{"key":"10.3233\/HAB-220003_ref28","doi-asserted-by":"publisher","first-page":"17698","DOI":"10.1038\/s41598-020-74904-1","article-title":"Rapid Production of SARS-CoV-2 Receptor Binding Domain (RBD) and Spike Specific Monoclonal Antibody CR3022 in Nicotiana benthamiana","volume":"10","author":"Rattanapisit","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.3233\/HAB-220003_ref29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.virol.2009.07.018","article-title":"Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity","volume":"393","author":"Du","year":"2009","journal-title":"Virology"},{"key":"10.3233\/HAB-220003_ref30","doi-asserted-by":"publisher","first-page":"113182","DOI":"10.1016\/j.jim.2021.113182","article-title":"Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19","volume":"500","author":"Villafa\u00f1e","year":"2022","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.3233\/HAB-220003_ref31","doi-asserted-by":"publisher","first-page":"e1009161","DOI":"10.1371\/journal.ppat.1009161","article-title":"Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina","volume":"17","author":"Ojeda","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.3233\/HAB-220003_ref32","doi-asserted-by":"publisher","first-page":"102915","DOI":"10.1016\/j.ebiom.2020.102915","article-title":"Serologic responses to SARSCoV-2 infection among hospital staff with mild disease in eastern France","volume":"59","author":"Fafi-Kremer","year":"2020","journal-title":"EBioMedicine"},{"key":"10.3233\/HAB-220003_ref33","doi-asserted-by":"publisher","first-page":"e70658","DOI":"10.7554\/eLife.70658","article-title":"Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics","volume":"10","author":"Barton","year":"2021","journal-title":"Elife"},{"key":"10.3233\/HAB-220003_ref34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fpubh.2017.00307","article-title":"Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice","volume":"5","author":"Trevethan","year":"2017","journal-title":"Front Public Health"}],"container-title":["Human Antibodies"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/HAB-220003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:22:39Z","timestamp":1777447359000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/HAB-220003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":33,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/hab-220003","relation":{},"ISSN":["1875-869X","1093-2607"],"issn-type":[{"value":"1875-869X","type":"electronic"},{"value":"1093-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,12]]}}}